VKH
IMMU

Virtu KCG Holdings’s Immunomedics Inc IMMU Stock Holding History

Virtu KCG Holdings’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$184K Sell
20,819
-77,443
-79% -$544K 0.01% 2196
2017
Q1 		$636K Buy
+98,262
New +$498K 0.02% 1130
2016
Q4 		– Sell
-56,892
Closed -$185K – 3963
2016
Q3 		$185K Buy
56,892
+11,071
+24% +$31K ﹤0.01% 2407
2016
Q2 		$106K Sell
45,821
-10,934
-19% -$36.5K ﹤0.01% 2525
2016
Q1 		$142K Buy
56,755
+28,496
+101% +$64.1K ﹤0.01% 2230
2015
Q4 		$87K Buy
28,259
+4,776
+20% +$13.3K ﹤0.01% 3029
2015
Q3 		$40K Buy
23,483
+3,282
+16% +$8.38K ﹤0.01% 3045
2015
Q2 		$82K Sell
20,201
-9,564
-32% -$39.1K ﹤0.01% 2972
2015
Q1 		$114K Buy
+29,765
New +$129K ﹤0.01% 2621
2014
Q4 		– Sell
-16,953
Closed -$63K – 4387
2014
Q3 		$63K Buy
16,953
+4,860
+40% +$16.4K ﹤0.01% 3301
2014
Q2 		$44K Buy
+12,093
New +$44.4K ﹤0.01% 3446
2014
Q1 		– Sell
-27,309
Closed -$125K – 4276
2013
Q4 		$125K Buy
+27,309
New +$122K ﹤0.01% 3369

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Virtu KCG Holdings's IMMU Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Immunomedics Inc (IMMU) stake by 79% in Q2 2017, selling an estimated $544K and leaving 20,819 shares worth $184K. The position accounts for 0.01% of the portfolio, ranked #2196.

Virtu KCG Holdings first reported a position in IMMU in Q4 2013 and has held it in 12 quarters since. The position peaked at $636K in Q1 2017. 130 funds tracked by Wall St. Rank hold IMMU as of Q2 2017.

  • Virtu KCG Holdings held 20,819 shares of Immunomedics Inc worth $184K as of Q2 2017.
  • Virtu KCG Holdings sold 77,443 Immunomedics Inc shares in Q2 2017, an estimated $544K.
  • Immunomedics Inc made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2196 holding.
  • Virtu KCG Holdings first reported a position in Immunomedics Inc in Q4 2013 and has held it in 12 quarters since.
  • Virtu KCG Holdings's Immunomedics Inc position peaked at $636K in Q1 2017.
  • 130 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.